Table 1. Chronic inflammatory diseases in which zonulin has been linked as a biomarker of gut permeability.
Disease | Model | References |
---|---|---|
Aging | Human | 37, 38 |
Ankylosis spondylitis | Human | 39 |
Attention deficit hyperactivity disorder | Human | 40 |
Autism | Human | 41, 42 |
Celiac disease | Human | 15– 20, 23– 27, 43– 48 |
Chronic fatigue syndrome/myalgic encephalomyelitis | Human | 49 |
Colitis – inflammatory bowel diseases | Human | 50, 51 |
Colitis | Mouse | 52 |
Environmental enteric dysfunction | Human | 53 |
Gestational diabetes | Human | 54, 55 |
Glioma | Human | 56 |
Glioma | Cell | 57 |
Insulin resistance | Human | 58 |
Irritable bowel syndrome | Human | 59, 60 |
Hyperlipidemia | Human | 61 |
HIV | Human | 62– 66 |
Major depressive disorders | Human | 67, 68 |
Multiple sclerosis | Mouse | 69 |
Multiple sclerosis | Human | 70 |
Necrotizing enterocolitis | Rat | 71 |
Necrotizing enterocolitis | Human | 72 |
Non-alcoholic fatty liver disease | Human | 73– 77 |
Non-celiac gluten sensitivity | Human | 53, 78 |
Obesity | Human | 79– 87 |
Schizophrenia | Human | 41, 88, 89 |
Sepsis | Human | 90 |
Type 1 diabetes | Rat | 91 |
Type 1 diabetes | Human | 92, 93 |
Type 2 diabetes | Human | 94, 95 |